Skip to main content

HOSCON seeks to takeover pipeline surveillance contracts

HOSCON seeks to takeover pipeline surveillance contracts

Niger Delta leaders give condition for termination of amnesty programme

Oil-bearing communities, under the aegis of Host Communities of Nigeria, Producing Oil and Gas, HOSCON, has called for the termination of all existing oil pipeline surveillance contracts across the country, accusing the current contracts of fuelling crisis in the Niger Delta.

Speaking to Vanguard in Abuja, National Chairman of HOSCON, Dr Mike Emuh, also accused the government of violating the provisions of the local content initiative by awarding Nigeria’s waterways’ surveillance contract to an Israeli firm.

He said: “Some of the existing contractors have constituted themselves into cabal and principalities; they are the problems of the Niger Delta. They rank among the most corrupt entities. How can you pay over $20 million to a contractor every month in the name of pipeline surveillance, along numerous oil mining leases as far as to the Trans Forcados Pipeline, TFP.

“This is just only one or two individuals making this huge amount of money every month, while the masses, especially the youths, are suffering. This was what made us to engage 10 persons each from oil-bearing and impacted communities, to make up the 10,000 youths we are advocating should be given the contracts. It is crucial to inject new blood and new vigour into the system.

“Another government agency has a security arrangement whereby it pays about $20 million monthly to an Israeli firm. Why not follow the Nigerian Content Act by giving that contract to Nigerian firms. The contract is seemingly to guard against piracy in the Gulf of Guinea.

“The Minister of Transportation needs to look into this issue to know why we are paying this huge sum of money to an Israeli firm. HOSCON is drawing the attention of the Minister of Transport to that contract.

“We are also asking the Minister of State for Petroleum Resources to make sure that pipeline surveillance contracts are awarded to host communities.

ALSO READ: National Gas Expansion Programme: President Buhari to launch autogas scheme Dec 1

He should not be seen to be collaborating with the contractors, who have formed themselves into a cabal, and who are destroying the system through the surveillance contracts.

“The government should give pipeline surveillance contracts to the host communities so that the 10,000 youths that had been engaged and trained in readiness for this duty would resume work.

“The government should give at least 40 per cent of the pipeline surveillance contracts to the host communities; leave 40 per cent for existing contractors and 20 per cent for new contractors.

“Host communities know the contractors in charge of pipeline surveillance and maintenance; we know those involved in bush loading, oil theft; owners of shuttling vessels and the brains behind illegal refineries.”

He called on the Federal Government to implement the four-point demand of HOSCON, adding that the ceasefire agreement reached with the Reformed Niger Delta Avengers, RNDA, militants and youths of the Niger Delta should be respected.

Vanguard News Nigeria

The post HOSCON seeks to takeover pipeline surveillance contracts appeared first on Vanguard News.


by Rasheed Sobowale via Vanguard News https://ift.tt/3o8H8yk Best Known Member of the Cabinet Wikipedia

Comments

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...